Another clinical study of locally advanced ESCC also detected a statistically significant correlation between CD8+ T cells content, rather than other TIL subsets, and clinical response, with improved CRR (p = 0.004) and prolonged PFS (p = 0.005) (23). The gene discussed is CD8A; the disease is esophageal squamous cell carcinoma.